Flock, smart-money disclosures made readable

Crinetics Pharmaceuticals In

CRNXNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−111,100 sh · $9.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Deardorf Caren
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−1,000 sh · $85.0K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Vivaldi Coelho Rogerio
Crinetics Pharmaceuticals In · NASDAQ
−13,300 sh · $1.1M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Wierenga Wendell
Crinetics Pharmaceuticals In · NASDAQ
−116,146 sh · $9.9M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−111,100 sh · $9.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Nichols Weston
Crinetics Pharmaceuticals In · NASDAQ
−16,300 sh · $1.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Betz Stephen F.
Crinetics Pharmaceuticals In · NASDAQ
−58,286 sh · $5.0M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−176,663 sh · $15.0M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Wierenga Wendell
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 35 disclosures

REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−110,000 sh · $9.3M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−111,100 sh · $9.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−106,000 sh · $9.0M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Fust Matthew K
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−111,100 sh · $9.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−100,000 sh · $8.5M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Vivaldi Coelho Rogerio
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−80,000 sh · $6.8M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−136,805 sh · $11.6M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Schilke Tobin
Crinetics Pharmaceuticals In · NASDAQ
−7,956 sh · $676.3K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Schilke Tobin
Crinetics Pharmaceuticals In · NASDAQ
−71,471 sh · $6.1M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Kalofonos Isabel
Crinetics Pharmaceuticals In · NASDAQ
−34,000 sh · $2.9M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Okey Stephanie
Crinetics Pharmaceuticals In · NASDAQ
−6,400 sh · $544.0K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Bedrosian Camille L
Crinetics Pharmaceuticals In · NASDAQ
−16,300 sh · $1.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Betz Stephen F.
Crinetics Pharmaceuticals In · NASDAQ
−79,650 sh · $6.8M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Kalofonos Isabel
Crinetics Pharmaceuticals In · NASDAQ
−1,669 sh · $141.9K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Okey Stephanie
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Struthers Richard Scott
Crinetics Pharmaceuticals In · NASDAQ
−248,043 sh · $21.1M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Bedrosian Camille L
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Deardorf Caren
Crinetics Pharmaceuticals In · NASDAQ
−16,300 sh · $1.4M
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Nichols Weston
Crinetics Pharmaceuticals In · NASDAQ
−5,925 sh · $503.6K
Filed 1 Sept 2026SEC Form 4view source
REDUCEDStale
Fust Matthew K
Crinetics Pharmaceuticals In · NASDAQ
−22,836 sh · $1.9M
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Schilke Tobin
Crinetics Pharmaceuticals In · NASDAQ
+471 sh
Filed 24 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Crinetics Pharmaceuticals In · NASDAQ
87,299 sh · $3.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Crinetics Pharmaceuticals In · NASDAQ
6,230,371 sh · $279.1M
Filed 30 Jun 2024SEC 13Fview source